Abstract
Get full access to this article
View all access options for this article.
References
1.
Cooper
DS
,
Doherty
GM
,
Haugen
BR
,
Kloos
RT
,
Lee
SL
,
Mandel
SJ
,
Mazzaferri
EL
,
McIver
B
,
Pacini
F
,
Schlumberger
M
,
Sherman
SI
,
Steward
DL
,
Tuttle
RM
. 2009 . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer . Thyroid , 19 :1167 –1214 .
2.
Greene
FL
. 2002 . AJCC Cancer Staging Manual , 6th . Springer-Verlag : New York .
3.
Preissner
CM
,
Dodge
LA
,
O'Kane
DJ
,
Singh
RJ
,
Grebe
SK
. 2005 . Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays . Clin Chem , 51 :208 –210 .
4.
Preissner
CM
,
O'Kane
DJ
,
Singh
RJ
,
Morris
JC
,
Grebe
SK
. 2003 . Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays . J Clin Endocrinol Metab , 88 :3069 –3074 .
5.
Chiovato
L
,
Latrofa
F
,
Braverman
LE
,
Pacini
F
,
Capezzone
M
,
Masserini
L
,
Grasso
L
,
Pinchera
A
. 2003 . Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens . Ann Intern Med , 139 :346 –351 .
6.
Spencer
CA
,
Takeuchi
M
,
Kazarosyan
M
,
Wang
CC
,
Guttler
RB
,
Singer
PA
,
Fatemi
S
,
LoPresti
JS
,
Nicoloff
JT
. 1998 . Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma . J Clin Endocrinol Metab , 83 :1121 –1127 .